Clinical Trial Update: Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating PET imaging with 18F-fludarabine for initial assessment and end-treatment evaluation in symptomatic multiple myeloma; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• 18F-Fludarabine (Fludarabine-18F)

Snippet

Sponsor: Nantes University Hospital | Conditions: Myeloma | Phase 1 | Status: RECRUITING